Summary
Companys report, “Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”, is an essential source of information and analysis on the global allergic conjunctivitis therapeutics market. The report identifies the key trends shaping and driving the global market. The report also provides insights into the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global allergic conjunctivitis therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Companys team of industry experts.
Company estimates that the global allergic conjunctivitis therapeutics market was valued at $970m in 2010, which is expected to grow at a Compound Annual Growth Rate (CAGR) of 14.3% over the next eight years, to reach $2.8bn by 2018. The increase in disease awareness is expected to lead to a growth in the diagnosed and treated population which will be further complemented by rising compliance due to the availability of a sufficient number of treatment options including branded, generics and OTC (Over the Counter) products. The increase in the treated patient population, the increasing uptake of medications and the rising compliance will be the primary drivers for the growth of the allergic conjunctivitis therapeutics market in the future. There are no major pipeline products which are expected to drive the market. The major late stage products in the allergic conjunctivitis therapeutics pipeline are modified pollen extracts which cater to a niche population only.
Scope
The report provides information on the key drivers and challenges of the Allergic Conjunctivitis Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Allergic Conjunctivitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Allergic Conjunctivitis Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Allergic Conjunctivitis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Allergic Conjunctivitis Therapeutics market
For more information, please visit:
http://www.aarkstore.com/reports/Allergic-Conjunctivitis-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2018-155500.html
Or email us at contact@aarkstore.com or call +918149852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No:+08149852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://www.emarketreports.com
Follow us on twitter: http://twitter.com/aarkstoredotcom
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstoreenterprise
Companys report, “Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”, is an essential source of information and analysis on the global allergic conjunctivitis therapeutics market. The report identifies the key trends shaping and driving the global market. The report also provides insights into the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global allergic conjunctivitis therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Companys team of industry experts.
Company estimates that the global allergic conjunctivitis therapeutics market was valued at $970m in 2010, which is expected to grow at a Compound Annual Growth Rate (CAGR) of 14.3% over the next eight years, to reach $2.8bn by 2018. The increase in disease awareness is expected to lead to a growth in the diagnosed and treated population which will be further complemented by rising compliance due to the availability of a sufficient number of treatment options including branded, generics and OTC (Over the Counter) products. The increase in the treated patient population, the increasing uptake of medications and the rising compliance will be the primary drivers for the growth of the allergic conjunctivitis therapeutics market in the future. There are no major pipeline products which are expected to drive the market. The major late stage products in the allergic conjunctivitis therapeutics pipeline are modified pollen extracts which cater to a niche population only.
Scope
The report provides information on the key drivers and challenges of the Allergic Conjunctivitis Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Allergic Conjunctivitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Allergic Conjunctivitis Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Allergic Conjunctivitis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Allergic Conjunctivitis Therapeutics market
For more information, please visit:
http://www.aarkstore.com/reports/Allergic-Conjunctivitis-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2018-155500.html
Or email us at contact@aarkstore.com or call +918149852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No:+08149852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://www.emarketreports.com
Follow us on twitter: http://twitter.com/aarkstoredotcom
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstoreenterprise
No comments:
Post a Comment